Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1

COPENHAGEN, Denmark, July 12, 2026 – Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology™ platform, presents new data further supporting the multi-component concept of its cytomegalovirus (CMV) vaccine program EVX-V1. Source: globenewswire Country: United States

American Home Water & Air Introduces The Governor, a Smart Water Softener with Integrated Leak Detection Technology

Phoenix, Arizona, July 12, 2026 (GLOBE NEWSWIRE) — American Home Water & Air today announced the introduction of The Governor, a new smart water softener designed to combine water treatment functionality with integrated leak detection capabilities. The launch marks an expansion of the company’s residential water treatment offerings and reflects a growing focus on solutions … Read more

GNS Investors Have Opportunity to Lead Genius Group Limited Securities Fraud Lawsuit Against Citadel Securities LLC and Virtu Americas LLC

NEW YORK, July 12, 2026 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers or sellers of securities of Genius Group Limited (NYSE American: GNS) between April 12, 2022 and May 30, 2025, inclusive (the “Class Period”), of the important August 28,… Source: prnewswire Country: United States

Best Tech Stocks Right Now

The post Best Tech Stocks Right Now by Shanthi Rexaline appeared first on Benzinga . Visit Benzinga to get more great content like this. Invest in the best tech stocks today with Webull or Robinhood. The technology sector is made up of companies that operate in the semiconductor, artificial intelligence (AI), software, computer hardware, and … Read more

Hemab Therapeutics Presents New Clinical Data from HMB-002 in Von Willebrand Disease and Introduces HMB-003 for Heavy Menstrual Bleeding at the ISTH 2026 Congress

HMB-002 clinical data demonstrate proof of mechanism, with dose-dependent, greater than or equal to 2.4-fold peak increases in Von Willebrand Factor (VWF) and Factor VIII (FVIII), normalization of peak thrombin generation and activated partial thromboplastin time (APTT), and durability supporting potential monthly subcutaneous dosing Source: globenewswire Country: United States